NCT04355845View on ClinicalTrials.gov

A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS.

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 15, 2020

Primary Completion Date

August 10, 2020

Study Completion Date

August 10, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

Sumatriptan

25 milligrams (mg) single dose tablet

DRUG

PF-06651600

PF-06651600 400 mg single dose

Trial Locations (1)

06511

New Haven Clinical Research Unit, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04355845 - A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS. | Biotech Hunter | Biotech Hunter